www.ADHDMedEd.com

Targeted CME to address clinical challenges.

Overview

The first telesymposium series in this broad CME initiative, “Focus on Diagnosis,” briefly reviews recent data on the epidemiology, neurobiology, and prevalence of ADHD, along with common psychiatric comorbidities. The activity then examines the assessment and diagnosis of ADHD in adolescents and adults.

The second telesymposium, “Focus on Treatment,” outlines pharmacologic and psychosocial treatment strategies for adolescent and adult patients with ADHD. Data from recent clinical trials of stimulant and nonstimulant medications will be examined for efficacy and safety, and second-line, off-label use of medications in adolescents and adults with ADHD will be discussed.

The third telesymposium, “Focus on Complex Patients,” offers a discussion of treatment strategies and adjustments that may be necessary for adolescent and adult patients with ADHD who do not respond to standard pharmacotherapy, are nonadherent to treatment, or may need a more intensive individualized multimodal approach.

Target Audience

Psychiatrists and primary care physicians involved in the treatment of patients with ADHD

Financial and Unlabeled Use Disclosures

The relevant financial relationships of those persons in a position to control the content of this CME activity will be disclosed at the telesymposium. Participants are advised that this CME activity will contain references to unlabeled/unapproved/investigational uses of drugs to treat ADHD.

Accreditation/Designation of Credit Statements

Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Veritas Institute for Medical Education, Inc. designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Sponsorship and Support

Sponsored by Veritas Institute for

Medical Education, Inc.

Supported by an educational grant from McNeil Pediatrics, Division of McNeil-PPC, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Method of Participation

• Participate in the telesymposium

• Complete the CME Activity Evaluation and Request for Credit Form

• Fax or mail the CME Activity Evaluation and Request for Credit Form to Veritas Institute for Medical Education, Inc.

• Your CME certificate will arrive within 2 weeks. This activity is provided free of charge to participating physicians.

Comprehensive Care for Patients With ADHD:

A Practical, Interactive Initiative

Telesymposium Series 1 – Focus on Diagnosis

            Learning Objectives:

1. You will be better able to diagnose ADHD and differentiate it from common psychiatric comorbidities.
2. You will be able to explain the impairments and impact of untreated ADHD on adolescent and adult patients and the importance of treating the disorder.

Telesymposium Series 2 – Focus on Treatment

            Learning Objectives:

1. You will be able to develop a multimodal treatment plan tailored to the individual patient, which may include medication, psychosocial treatment, organizational training, education, and accommodations in school and at work.
2. You will be able to select and titrate pharmacologic treatments that improve symptomatic behavior and cognitive functioning in adolescents and adults with ADHD.

Telesymposium Series 3 – Focus on Complex Patients

            Learning Objective:

1. You will be better able to treat patients with ADHD who are resistant to treatment with stimulants and/or have psychiatric or medical comorbidities.

Ask the experts your burning questions!

At the end of each presentation, you will be given the opportunity to ask national thought leaders in ADHD the questions that matter to you most. Faculty will discuss your most difficult clinical cases and address emerging treatment options, as well as strategies for diagnosing ADHD in the presence of other comorbidities.